Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

10.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.7K
The Electron Transport Chain01:30

The Electron Transport Chain

16.0K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

7.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
7.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

464
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
464
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

3.0K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Convergent Strategy for Factor Xa Inhibition: Synthesis, Bioinformatics, and Biological Analysis of 3,5-Disubstituted Isoxazoles.

Archiv der Pharmazie·2026
Same author

Eco-Friendly Copper Recovery: Insights to Algal and Agricultural Waste Application.

Water environment research : a research publication of the Water Environment Federation·2026
Same author

Biosynthesis of cerium and gadolinium nanoparticles by Pseudomonas putida KT2440 enables sustainable rare earth elements utilization.

Scientific reports·2026
Same author

A juglone derivative that disrupts mitochondrial redox metabolism, inhibiting the breast fibroblast-cancer cell pro-migratory signaling induced by doxorubicin.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Comparative evaluation of multiplex bead assay, polymerase chain reaction, and rapid diagnostic test for P. falciparum detection in community surveys in Malawi.

Malaria journal·2026
Same author

PSG6: A mitochondrially-targeted gentisic acid derivative exerts antiplatelet action via mitochondrial complex I inhibition.

Redox biology·2026

Related Experiment Video

Updated: May 31, 2025

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.2K

MITOCDNB DECREASES PLATELET ACTIVATION THROUGH ITS SELECTIVE ACTION ON MITOCHONDRIAL THIOREDOXIN REDUCTASE.

Diego Méndez1, Francisca Tellería1, Marcelo Alarcón1

  • 1Thrombosis and Healthy Aging Research Center, MIBI: Interdisciplinary Group on Mitochondrial Targeting and Bioenergetics, Medical Technology School, Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, Universidad de Talca, Talca, Chile.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 22, 2025
PubMed
Summary

Researchers identified MitoCDNB, a novel mitochondria-targeting compound, as a potent platelet inhibitor. This new agent effectively reduces platelet activation and aggregation, offering a promising approach for preventing thrombus formation with potentially fewer side effects.

Keywords:
AntiplateletMitochondrial TargetingPlatelet BioenergeticsThioredoxin Reductase 2Triphenylphosphonium Cation

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

163
Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

567

Related Experiment Videos

Last Updated: May 31, 2025

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.2K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

163
Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

567

Area of Science:

  • Biochemistry
  • Pharmacology
  • Mitochondrial Medicine

Background:

  • Platelet inhibition is crucial for managing thrombosis.
  • Platelet activation is intrinsically linked to mitochondrial function.
  • There is a need for novel antiplatelet agents with targeted mechanisms.

Purpose of the Study:

  • To discover and characterize a new mitochondria-targeting compound with antiplatelet properties.
  • To evaluate the safety and efficacy of the compound in vitro.
  • To elucidate the mechanism of action of the novel compound on platelet function.

Main Methods:

  • Cytotoxicity and viability assays on human platelets.
  • Assessment of platelet aggregation and activation.
  • Analysis of mitochondrial function, respiration, and thioredoxin reductase 2 (TrxR2) activity.
  • Evaluation of the compound MitoCDNB (5-chloro-2,4-dinitrophenylamino-TPP+).

Main Results:

  • MitoCDNB exhibited potent, mitochondria-selective antiplatelet effects.
  • The compound inhibited TrxR2 enzymatic activity and collagen-stimulated mitochondrial respiration.
  • MitoCDNB successfully prevented platelet aggregation and activation in vitro.
  • No significant cytotoxicity was observed at effective concentrations.

Conclusions:

  • MitoCDNB represents the first compound shown to inhibit platelet activation via targeting mitochondrial TrxR2 and respiration.
  • This novel mitochondria-targeting strategy offers a new therapeutic avenue for antiplatelet therapy.
  • Further development of MitoCDNB could lead to antiplatelet drugs with minimized systemic risks.